Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Man asleep wearing sleep tracker on his wrist © Andrey_Popov/ Shutterstock

The COVID-19 pandemic brought changes to the way people work, socialise and spend leisure time. It also brought stressors in the form of health concerns, social isolation, financial hardship, home-schooling, and uncertainty about the future. All of this combined has had a major impact on sleep and psychological well-being.

In June 2020, an international group of researchers led by Professor Colin Espie from the Sleep and Circadian Neuroscience Institute at the University of Oxford and Professor Charles Morin, Department of Psychology, Laval University, set out to investigate the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
This study documented the prevalence of clinical cases of insomnia, anxiety, and depression and selected risk factors (COVID-19, confinement, financial burden, social isolation) during the first wave of the pandemic from May to August 2020. Over 22,000 adults from 13 countries across four continents completed a web-based survey about their sleep and psychological symptoms.

Over a third of respondents reported clinical insomnia symptoms, and almost a fifth met criteria for a probable insomnia disorder. Over a quarter of participants had probable anxiety and almost a quarter probable depression. Risks of insomnia were higher among participants who reported having had COVID-19, who reported greater financial burden, were in confinement for a period of four to five weeks, and living alone or with more than five people in same household.

Professor Colin Espie says: 'Health authorities must deploy sleep and mental health prevention programmes, as well as clinical interventions to assist at-risk individuals and reduce long-term adverse health outcomes. Research shows that when you treat insomnia, you often not only see improvements in sleep, but reductions in anxiety and depressive symptoms, and improvement in mental health and wellbeing. This study provides further evidence of the impact of sleep on mental health and how we can begin addressing the mental health crisis through evidenced-based insomnia interventions.'

Read the full paper

Similar stories

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Appointment of the new Margaret Ogilvie Professor of Ophthamology

We are delighted to announce that Professor Denize Atan has joined the department as Margaret Ogilvie Professor of Ophthamology and a Consultant in Neuro-ophthalmology at the Oxford Eye Hospital.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy

A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.